Skip to main content
. 2023 Nov 14;13:1258951. doi: 10.3389/fonc.2023.1258951

Table 3.

Contribution of the expression of AHNAK to survival by univariate Cox regression analysis in cancers.

Cancer Type OS PFS DFS DSS
HR 95%CI P HR 95%CI P HR 95%CI P-value HR 95%CI P
ACC 1.129 0.750-1.698 0.561 1.170 0.847-1.617 0.341 1.210 0.636-2.300 0.561 1.091 0.715-1.665 0.686
BLCA 1.380 1.180-1.615 0.000* 1.290 1.103-1.508 0.001* 0.956 0.667-1.371 0.807 1.442 1.188-1.750 0.000*
BRCA 0.980 0.827-1.160 0.812 0.941 0.793-1.117 0.489 0.857 0.690-1.064 0.162 0.870 0.699-1.082 0.211
CESC 1.335 0.997-1.787 0.053 1.068 0.810-1.408 0.642 0.886 0.567-1.383 0.593 1.278 0.918-1.780 0.146
CHOL 0.874 0.541-1.411 0.582 0.953 0.601-1.511 0.837 1.411 0.672-2.960 0.363 0.947 0.567-1.583 0.836
COAD 1.049 0.844-1.304 0.667 1.064 0.885-1.279 0.508 1.095 0.736-1.630 0.653 1.058 0.819-1.366 0.667
DLBC 1.236 0.672-2.275 0.495 1.280 0.763-2.148 0.350 1.278 0.512-3.192 0.599 1.232 0.487-3.115 0.659
ESCA 0.720 0.542-0.957 0.024* 0.794 0.614-1.027 0.079 0.940 0.569-1.551 0.807 0.742 0.534-1.032 0.076
GBM 1.121 0.949-1.325 0.179 1.113 0.930-1.331 0.243 1.143 0.954-1.370 0.147
HNSC 1.036 0.879-1.221 0.676 0.911 0.771-1.075 0.270 0.918 0.580-1.453 0.716 1.011 0.817-1.251 0.921
KICH 0.774 0.320-1.871 0.569 0.665 0.303-1.458 0.309 0.697 0.151-3.215 0.643 0.859 0.312-2.367 0.769
KIRC 0.757 0.641-0.894 0.001* 0.837 0.698-1.003 0.054 1.117 0.634-1.969 0.702 0.708 0.579-0.867 0.001*
KIRP 0.930 0.664-1.302 0.672 0.690 0.530-0.898 0.006* 0.743 0.500-1.104 0.141 0.685 0.469-1.001 0.051
LAML 1.142 0.926-1.409 0.214
LGG 0.880 0.733-1.057 0.172 0.929 0.801-1.079 0.335 0.978 0.618-1.546 0.923 0.937 0.771-1.139 0.512
LIHC 0.966 0.777-1.202 0.758 0.989 0.816-1.198 0.910 0.860 0.693-1.068 0.172 0.939 0.707-1.248 0.665
LUAD 1.091 0.958-1.242 0.190 1.042 0.922-1.176 0.511 0.957 0.798-1.147 0.632 1.103 0.936-1.301 0.241
LUSC 1.069 0.919-1.244 0.387 1.188 0.982-1.437 0.077 0.946 0.714-1.254 0.699 1.141 0.894-1.456 0.290
MESO 1.156 0.803-1.665 0.436 1.097 0.755-1.594 0.628 0.791 0.342-1.827 0.583 1.068 0.670-1.701 0.783
OV 1.142 0.985-1.324 0.079 0.957 0.837-1.093 0.514 0.912 0.751-1.106 0.349 1.166 0.994-1.367 0.059
PAAD 1.743 1.287-2.36 0.000* 1.701 1.284-2.252 0.000* 2.870 1.409-5.846 0.004* 1.775 1.261-2.499 0.001*
PCPG 1.006 0.489-2.069 0.988 0.951 0.618-1.464 0.820 1.523 0.554-4.186 0.414 1.178 0.504-2.754 0.706
PRAD 0.669 0.333-1.341 0.257 0.779 0.602-1.008 0.057 0.779 0.488-1.242 0.294 0.438 0.157-1.220 0.114
READ 0.769 0.490-1.209 0.255 1.004 0.685-1.471 0.985 1.290 0.425-3.911 0.653 0.528 0.293-0.951 0.034*
SARC 0.758 0.594-0.967 0.026* 0.777 0.636-0.949 0.014* 0.865 0.651-1.148 0.316 0.654 0.499-0.858 0.002*
SKCM 0.981 0.863-1.114 0.763 0.955 0.858-1.063 0.401 0.937 0.818-1.073 0.346
STAD 1.113 0.929-1.333 0.244 1.105 0.910-1.343 0.313 1.149 0.813-1.623 0.431 1.122 0.893-1.411 0.324
TGCT 1.619 0.528-4.959 0.399 1.074 0.787-1.464 0.654 0.971 0.695-1.358 0.865 1.792 0.524-6.127 0.352
THCA 1.224 0.619-2.421 0.561 0.908 0.639-1.291 0.591 1.076 0.658-1.759 0.770 0.707 0.275-1.817 0.472
THYM 1.019 0.617-1.683 0.941 0.912 0.652-1.276 0.591 0.644 0.262-1.583 0.338
UCEC 0.984 0.777-1.247 0.895 0.917 0.749-1.124 0.405 0.846 0.628-1.141 0.274 1.039 0.779-1.386 0.793
UCS 0.823 0.574-1.180 0.289 0.773 0.542-1.102 0.155 0.572 0.281-1.166 0.124 0.708 0.481-1.043 0.081
UVM 0.686 0.344-1.365 0.283 0.922 0.509-1.670 0.789 0.652 0.314-1.353 0.251

OS, Overall survival, PFS, Progression free survival, DFS, Disease free survival, DSS, Disease specific survival. *, P-value < 0.05 was considered statistically significant.